SMS Pharmaceuticals Signs Rs 50 Crore Loan Agreement with Subsidiary SMS Peptides
SMS Pharmaceuticals Ltd 路 Others (Uncategorized) 路 30 Oct 2026, 10:51 pm
SMS Pharmaceuticals Signs Rs 50 Crore Loan Agreement with Subsidiary SMS Peptides SMS Pharmaceuticals Limited executed a loan agreement on 30th Oct'26 to extend an unsecured loan facility of up to Rs 50 Crore in one or more tranches to its 99.99%-owned subsidiary, SMS Peptides Private Limited. The facility is intended to fund the subsidiary's business operations and constitutes an arm's-length related-party transaction with common directors. As of the disclosure date, the outstanding loan amount remains nil, and the agreement confers no special rights or equity conversion terms.
Original exchange filing (PDF)
More announcements from SMS Pharmaceuticals Ltd
- Earnings Call Transcript 路 10 Nov 2026
- Investors Meet Audio Recording 路 05 Nov 2026
- Press release on Financial Results 路 05 Nov 2026
- Investor Presentation for quarter and half year ended September 30, 2026 路 04 Nov 2026
- Financial results and change in Company Secretary 路 04 Nov 2026
- SMS Pharmaceuticals Limited has informed the Exchange about General Updates 路 04 Nov 2026
- Change in Management_Company Secretary 路 04 Nov 2026
- SMS Pharmaceuticals Limited has informed the Exchange about Change in Company Secretary/Compliance Officer 路 04 Nov 2026
